Trailing Twelve Months Revenue Growth: Heron Therapeutics (HRTX)

Public company logo of Heron (HRTX)

The reliability of Heron Therapeutics (HRTX) is based on production outsourcing and the expansion of B2B contracts with clinics. This chart of trailing 12-month year-over-year revenue growth confirms this trend, where the -4.50 mark indicates the level of current momentum. Innovative extended-release systems reduce opioid dependence, while the active capture of the hospital segment proves the economic efficiency of the offered solutions.

Heron Therapeutics, Inc. (HRTX): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/19/2026

Heron Therapeutics, Inc. - analytical breakdowns and key metrics (HRTX)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:herontx.com
Brand item of herontx.com

This indicator measures the percentage change in total revenue over the last 12 months relative to the same period last year, reflecting the business scaling dynamics. By analyzing the 12-month rolling YoY revenue growth chart, an investor can assess the sales sustainability of Heron Therapeutics (HRTX) amid debt burdens and regulatory pressure on the pricing of new analgesic drugs.

Who Heron Therapeutics competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|NVCT (Nuvectis Pharma) - Revenue Dynamics YoY (Last Twelve Months)|Coherus Biosciences - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CRBP (Corbus Pharmaceuticals Holdings)|Cardiff Oncology - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)